Hints and tips:
...Panasonic made its first investment in Tesla in 2010, but it was under Tsuga that Panasonic decided to shift its focus to the automotive business after he pulled the plug on its plasma display panels and...
...Panasonic, still haunted by overinvestment in plasma TVs, was worried about pouring more into the battery business....
...Kazuhiro Tsuga, chief executive of the century-old technology group, often says the brand was so closely associated with plasma televisions that when it stopped making them five years ago, people no longer...
...Chartwatch Blood business Trade in human blood plasma between the US and China is flourishing....
...Talecris for $4bn....
...Two new plants — being developed by US-based Air Products and using advanced plasma gasification technology — were meant to take Teesside’s long-standing process industry expertise into new areas of renewable...
...Pooling resources alleviates pressure on squeezed R&D budgets, puts products on shelves faster – thus, at least in theory, boosting sales and profitability....
...Japanese companies pioneered thin plasma and LCD displays more than a decade ago....
...Grifols, which is still part-owned and run by the Grifols founding family in Spain, said the deal would create one of the world’s leading suppliers of plasma protein therapeutics products....
...Talecris Biotherapeutics, a maker of protein therapies, jumped 25.7 per cent to $20.01 after Grifols, Europe’s largest maker of blood plasma products, agreed to buy it for $4bn....
...of the Soviet Union’s greatest physicists, sits at his desk in a villa on the outskirts of Moscow, surrounded by the evidence of a 50-year career in science – books on non-linear diffraction and ionised plasmas...
...acquire US-listed rival Talecris Biotherapeutics for cash and stock....
...At least two sizeable healthcare companies are primed to price their IPOs within weeks – Talecris Biotherapeutics, a blood plasma provider, and Select Medical, a US hospital operator....
...Samsung said it would have the widest range of 3D TVs this year in both LED, LCD and plasma versions....
...The US Federal Trade Commission authorised a lawsuit to block the proposed $3.1bn acquisition of Talecris, a US plasma provider, by Australia’s CSL, over concerns that the deal would hurt competition and...
...“Cost and resource issues are largely to blame,” says Mr Nagrath....
...CSL, the world’s second largest blood plasma maker, rose as much as 5.8 per cent after saying it would abandon a $3.1bn plan to buy Talecris Biotherapeutics after regulators rejected the bid....
...The two firms bought Talecris – the former blood plasma business of Germany’s Bayer – for $303.5m in 2005. Talecris filed plans for an initial public offering more than a year ago....
...When Cerberus bought GMAC in November 2006, he realised problems with its mortgage arm, ResCap, meant the resources Cerberus thought it possessed against the approaching storm might well prove inadequate...
...Cerberus eyes Talecris sale instead of IPO Talecris Biotherapeutics, the blood plasma products maker that Cerberus Capital filed to take public last year, may instead be sold....
...“Companies are battling with their resources and trying not to stretch them too thin while maintaining a decent quality of life,” says Mr De Beer....
...In Taiwan, AU Optronics, a maker of LCD and plasma displays fell by 4.4 per cent to T$40.60 after disappointing second quarter profits on Thursday....
...Pioneer surged 12 per cent to Y1,165 after a local report said the Japanese maker of audio-visual products may withdraw from plasma display panel production....
...A rise in metal prices thanks to production problems in many mines across the world meant resources companies were the biggest gainers....
...Lacking the resources of its much larger rival, it will not launch a marketing blitz and will seek partnerships....
International Edition